Brief: Resonance Health Says Contracted By VGI Health Technology For Nash Phase II Clinical Study
25/01/2022 02:00
Jan 25 (Reuters) - Resonance Health Ltd RHT.AX :
* RESONANCE HEALTH LTD - CONTRACTED BY VGI HEALTH TECHNOLOGY
LTD
FOR NASH PHASE II CLINICAL STUDY
Source text for Eikon: ID:nASX3N29F6
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million